Foundations Investment Advisors LLC Grows Stock Holdings in CVS Health Corporation $CVS

Foundations Investment Advisors LLC lifted its stake in CVS Health Corporation (NYSE:CVS) by 13.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,333 shares of the pharmacy operator’s stock after purchasing an additional 1,096 shares during the quarter. Foundations Investment Advisors LLC’s holdings in CVS Health were worth $644,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Avion Wealth boosted its holdings in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares in the last quarter. Harbor Asset Planning Inc. purchased a new position in shares of CVS Health in the 2nd quarter worth about $30,000. Bell Investment Advisors Inc boosted its stake in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC grew its position in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the last quarter. Finally, ORG Partners LLC increased its stake in CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. The Goldman Sachs Group began coverage on shares of CVS Health in a report on Tuesday, October 14th. They set a “buy” rating and a $91.00 price target on the stock. Piper Sandler upped their price objective on CVS Health from $81.00 to $99.00 in a research report on Friday, October 31st. TD Cowen lifted their target price on CVS Health from $99.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, November 3rd. Raymond James Financial upped their price target on CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Finally, Robert W. Baird upgraded CVS Health from a “neutral” rating to an “outperform” rating and lifted their price objective for the stock from $71.00 to $82.00 in a report on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.41.

CVS Health Stock Performance

CVS stock opened at $77.93 on Wednesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.62. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $85.15. The company has a market cap of $98.93 billion, a P/E ratio of 205.08, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60. The stock’s fifty day moving average price is $77.98 and its 200-day moving average price is $70.09.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.CVS Health’s revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.